Login
News
European authorities approve Prepandrix™, a pre-pandemic vaccine for Avian Influenza virus
01 June 2008On May 19, 2008 GlaxoSmithKline announced that the European Medicines Agency (EMEA) has granted a marketing authorization in all 27 Europe member states for Prepandrix™, a pre-pandemic vaccine against Avian Influenza virus H5N1.
A pre-pandemic Avian Influenza virus vaccine consists in a...
Composition of Influenza vaccine for 2008-2009 season
27 February 2008On February 14, 2008, after reviewing global reports on viral activity, Influenza virus experts of the World Health Organization (WHO) announced their recommendations regarding the composition of the Influenza vaccine for use in the northern hemisphere during the forthcoming Influenza season. A...
Carraguard® is safe as microbicide but does not prevent HIV transmission
18 February 2008On February 18, 2008 the nonprofit research organization Population Council announced the results of a clinical Phase III trial completed in South Africa with the candidate microbicide Carraguard®. According to the sponsor, Carraguard® proved to be safe for vaginal use in women....
Conferences
15th Conference on Retroviruses and Opportunistic Infections (CROI)
Boston, MA; February 3-7, 2008 www.retroconference.org/2008/
21st International Conference on Antiviral Research (ICAR)
Le Centre Sheraton Hotel, Montreal, Quebec, Canada; April 13-17, 2008 http://isar.phrm.cf.ac.uk/node/31
18th Annual Clinical Care Options HIV Symposium
Rancho Las Palmas, Rancho Mirage, California; May 1-8, 2008 http://www.clinicalcareoptions.com/
Contact Antiviral InteliStrat
| E-mail: | info@antiviralintelistrat.com |
| Telephone: | 1-450-688-7101 |
| Fax: | 1-514-227-5315 |
| Corporate Address: | Antiviral InteliStrat Inc. 3077 Edouard-Montpetit, suite 406 Laval City, Prov. of Quebec Canada H7T 2K8 |